Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Embryonic Stem Cells

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.

Embryonic Stem Cells

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sustained efficacy and long-term outcomes of autologous oral mucosal epithelial cell sheet transplantation for pediatric esophageal anastomotic restenosis.

Scientific reports·2026

Same author

The Expression of Placental 17β-Hydroxysteroid Dehydrogenase Genes Is Associated with the Elevation of Active Androgens and Estrogens in Pregnant Women, but Does Not Affect 11-Oxygenated C19 Steroids.

International journal of molecular sciences·2026

Same author

In-utero cell transplantation for hypophosphatasia with gene-edited hESC-derived MSCs in a murine model.

Molecular therapy. Advances·2026

Same author

The feasibility of human embryonic stem cell (hESC)-derived cartilage for tracheoplasty.

Regenerative therapy·2025

Same author

Generation of implant-type tissue-engineered cartilage from human embryonic stem cell-derived chondrocytes.

Regenerative therapy·2025

Same author

Stable and functional human intestinal epithelium derived from induced pluripotent stem cells.

Drug metabolism and disposition: the biological fate of chemicals·2025

Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 5, 2026

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

[Cell source for regenerative medicine].

Akihiro Umezawa¹, Hatsune Makino

¹Department of Reproductive Biology, National Institute for Child Health and Development.

Nihon Rinsho. Japanese Journal of Clinical Medicine

|May 10, 2008

Summary

This summary is machine-generated.

Mesenchymal stem cells (MSCs) are promising for therapy due to their differentiation potential. Different sources of MSCs, like placenta and umbilical cord, show varied multipotency, influencing their therapeutic applications.

More Related Videos

Induced Pluripotent Stem Cell Generation from Blood Cells Using Sendai Virus and Centrifugation

Induced Pluripotent Stem Cell Generation from Blood Cells Using Sendai Virus and Centrifugation

Published on: December 21, 2016

Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector

Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector

Published on: October 31, 2012

Related Experiment Videos

Last Updated: Jul 5, 2026

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

Induced Pluripotent Stem Cell Generation from Blood Cells Using Sendai Virus and Centrifugation

Induced Pluripotent Stem Cell Generation from Blood Cells Using Sendai Virus and Centrifugation

Published on: December 21, 2016

Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector

Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector

Published on: October 31, 2012

Area of Science:

Regenerative Medicine
Cell Biology
Stem Cell Research

Background:

Mesenchymal stem cells (MSCs) possess multipotency and are investigated for cell-based therapies.
Clinical applications of human MSCs include treating graft-versus-host disease and osteogenesis imperfecta.
Previous studies demonstrated MSC differentiation into various cell types including cardiomyocytes and neurons.

Purpose of the Study:

To investigate the multipotency of mesenchymal stem cells (MSCs) from diverse sources.
To determine if MSC differentiation potential varies based on the tissue of origin.
To understand the implications of differential default states in ex vivo MSCs for therapeutic use.

Main Methods:

Isolation and culture of MSCs from various human tissues (placenta, endometrium, menstrual blood, umbilical cord, cartilage).
Assessment of MSC proliferation and differentiation capabilities.
Comparative analysis of differentiation potentials across different MSC sources.

Main Results:

MSCs were successfully isolated from multiple sources, including placenta, endometrium, menstrual blood, umbilical cord, and cartilage.
MSCs demonstrated multipotency, differentiating into various cell lineages.
Significant variations in differentiation potential were observed depending on the MSC source.
These findings suggest differential default states for MSCs from distinct origins ex vivo.

Conclusions:

Multiple human tissues serve as viable sources for multipotent mesenchymal stem cells (MSCs).
The differentiation potential of MSCs is source-dependent, indicating distinct ex vivo default states.
Understanding these source-specific characteristics is crucial for optimizing MSC-based therapeutic strategies.